The Annals of thoracic surgery · 2025
Enhanced Recovery After Thoracic Surgery: Postoperative Opioid Use by Preoperative Use Status and Risk Factors for New Persistent Opioid Use.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pratt Catherine G, Cheon Soyoung, Whitrock Jenna N, Moore Allison N, Wima Koffi, Budde Bradley, Starnes Sandra L, Van Haren Robert M
Аннотация
BACKGROUND: Enhanced recovery after surgery (ERAS) is associated with improved outcomes in thoracic surgery. Opioid-sparing analgesia is a key component of ERAS, but the effect based on preoperative opioid use is not well understood. This study aimed to evaluate the effects of ERAS based on preoperative opioid use and to identify factors associated with new persistent opioid use (NPOU).
METHODS: A prospectively maintained database of patients undergoing pulmonary resection was linked to the regional prescription drug monitoring program. Patients were stratified by preoperative opioid prescriptions filled in the preceding 12 months (naive or non-naive) and evaluated before and after ERAS implementation. A subset of NPOU patients was also evaluated.
RESULTS: Of the 371 patients included, 59.6% were naive and 40.4% non-naive to opioids preoperatively. ERAS was associated with reduction in total inpatient and discharge prescription morphine milligram equivalents in both groups, and average inpatient morphine milligram equivalents was reduced in non-naive users. In naive users, ERAS was associated with shorter length of stay and shorter chest tube duration. Of the 221 naive users, 10.9% were identified with NPOU postoperatively, and the rate of NPOU did not change with ERAS implementation.
CONCLUSIONS: An ERAS protocol was associated with reduced opioid use in patients undergoing pulmonary resection regardless of preoperative opioid use status. However, a subset of naive users had NPOU despite similar postoperative courses. Strategies are needed to identify risk factors and to individualize pain management in this population.
METHODS: A prospectively maintained database of patients undergoing pulmonary resection was linked to the regional prescription drug monitoring program. Patients were stratified by preoperative opioid prescriptions filled in the preceding 12 months (naive or non-naive) and evaluated before and after ERAS implementation. A subset of NPOU patients was also evaluated.
RESULTS: Of the 371 patients included, 59.6% were naive and 40.4% non-naive to opioids preoperatively. ERAS was associated with reduction in total inpatient and discharge prescription morphine milligram equivalents in both groups, and average inpatient morphine milligram equivalents was reduced in non-naive users. In naive users, ERAS was associated with shorter length of stay and shorter chest tube duration. Of the 221 naive users, 10.9% were identified with NPOU postoperatively, and the rate of NPOU did not change with ERAS implementation.
CONCLUSIONS: An ERAS protocol was associated with reduced opioid use in patients undergoing pulmonary resection regardless of preoperative opioid use status. However, a subset of naive users had NPOU despite similar postoperative courses. Strategies are needed to identify risk factors and to individualize pain management in this population.